Jennifer  Ku  to  Mycobacterium Infections, Nontuberculous
                            
                            
                                This is a "connection" page, showing publications  Jennifer  Ku  has written about  Mycobacterium Infections, Nontuberculous.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            3.463
         
        
        
     
 
    
        
        - 
            Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines. Clin Infect Dis. 2023 01 13; 76(2):338-341.
            
            
                Score: 0.818
             
- 
            Outcomes of Resectional Thoracic Surgery for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease in 105 Patients in the United States. Chest. 2022 02; 161(2):365-369.
            
            
                Score: 0.741
             
- 
            Validity of Diagnosis Code-Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients. Emerg Infect Dis. 2021 03; 27(3):982-985.
            
            
                Score: 0.718
             
- 
            'Lady Windermere's counterpart? Pulmonary nontuberculous mycobacteria in men with bronchiectasis. Diagn Microbiol Infect Dis. 2020 Feb; 96(2):114916.
            
            
                Score: 0.654
             
- 
            Mortality after Respiratory Isolation of Nontuberculous Mycobacteria. A Comparison of Patients Who Did and Did Not Meet Disease Criteria. Ann Am Thorac Soc. 2017 Jul; 14(7):1112-1119.
            
            
                Score: 0.139
             
- 
            Long-Term Outcomes in a Population-based Cohort with Respiratory Nontuberculous Mycobacteria Isolation. Ann Am Thorac Soc. 2017 07; 14(7):1120-1128.
            
            
                Score: 0.139
             
- 
            Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007-2012. Emerg Infect Dis. 2017 03; 23(3):533-535.
            
            
                Score: 0.136
             
- 
            The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease. Eur Respir J. 2015 Apr; 45(4):1177-9.
            
            
                Score: 0.118